Vendor, Missouri City, TX
Tenaci-T Therapeutics LLC
UEI MTRTYVL8N717, CAGE 01U66
1 award and $297,621 obligated between September 16, 2025 and September 14, 2026, 100% under full and open competition, against 55.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $297,621 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00012Definitive Contract, September 16, 2025, Full and Open Competition After Exclusion of Sources, 55 offersSolicitation | NIH NCINational Institutes of Health | FY2025 SBIR Concept Clearance Award for Topic Development of Therapeutic or Preventative Technologies for Treatment or Prevention of PediatrNAICS 541715, PSC AN11 | $297,621 |
- Places of performance
- Texas
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards